VoxNeuro Announces Collaboration with Boston University and Launch of Clinical Studies Focusing on Concussion and Alzheimer’s Disease

ORIGINAL ARTICLE, Business Wire, September 7, 2022

BOSTON–(BUSINESS WIRE)–VoxNeuro Inc. (“VoxNeuro” or the “Company”), a commercial stage Software-as-a-Medical-Device (SaMD) brain health company that analyzes brain biomarkers to assess cognitive function, announced a new partnership with Boston University (“BU”), a world-class institution and private research university at the forefront of neuroscience and neurotechnology.

In partnership with BU, VoxNeuro has launched two studies that will evaluate its cognitive health assessment platform in an outpatient setting to assess diagnostic accuracy. The studies will focus on patients suffering from mild-Traumatic Brain Injury (mTBI)/Concussion and Alzheimer’s disease, respectively.

On a combined basis, mTBI/Concussion and Alzheimer’s disease affect over ten million Americans annually, and the inefficiencies of current behavior-based screening methodologies results in considerable excess cost and time to patients, clinicians and the healthcare system. VoxNeuro’s cognitive health software is expected to provide additive diagnostic information to improve clinical management beyond traditional testing methods. This represents a significant step forward for brain health as VoxNeuro provides for better identification and management strategies.

The studies will be led by Dr. John Connolly, PhD, VoxNeuro’s Chief Science Officer and Dr. Kyle Ruiter, PhD, VoxNeuro’s Vice President of Clinical & Scientific Affairs, alongside co-investigators Dr. Andrew Budson, MD, Professor of Neurology at Boston University School of Medicine and Associate Director of Boston University’s Alzheimer’s Disease Research Center, and Dr. Katherine Turk, MD, Assistant Professor of Neurology at Boston University School of Medicine and co-Leader of the Outreach, Recruitment and Engagement Core at the Boston University Alzheimer’s Disease Research Center.


To continue reading, CLICK HERE


 likes / 0 Comments
Share this post: